We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oncolytics Biotech® Inc.'s Research Collaborators to Present Data on REOLYSIN® Clinical Trials

News   May 15, 2009

 
Oncolytics Biotech® Inc.'s Research Collaborators to Present Data on REOLYSIN® Clinical Trials
 
 
 

RELATED ARTICLES

“Smart Drug” Shows Promise for Metastatic Triple-Negative Breast Cancer

News

A new "smart drug" has shown promise for women with metastatic triple-negative breast cancer, based on data from a clinical trial at NewYork-Presbyterian/Columbia's Herbert Irving Comprehensive Cancer Center and other centers.

READ MORE

RNA Captured Interacting With Stress Granules

News

Individual RNA molecules have been captured interacting with stress granules, revealing how, when and where the RNAs move around – a process never before witnessed from start to finish.

READ MORE

Drug Combo Could Become New Standard Treatment for Advanced Kidney Cancer

News

A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a Phase 3 clinical trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE